Literature DB >> 18566601

Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium.

E M Yazlovitskaya1, A G Linkous, D K Thotala, K C Cuneo, D E Hallahan.   

Abstract

Radiosensitivity of various normal tissues is largely dependent on radiation-triggered signal transduction pathways. Radiation simultaneously initiates distinct signaling from both DNA damage and cell membrane. Specifically, DNA strand breaks initiate cell-cycle delay, strand-break repair or programmed cell death, whereas membrane-derived signaling through phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) enhances cell viability. Here, activation of cytosolic phospholipase A(2) (cPLA(2)) and production of the lipid second-messenger lysophosphatidylcholine were identified as initial events (within 2 min) required for radiation-induced activation of Akt and ERK1/2 in vascular endothelial cells. Inhibition of cPLA(2) significantly enhanced radiation-induced cytotoxicity due to an increased number of multinucleated giant cells and cell cycle-independent accumulation of cyclin B1 within 24-48 h of irradiation. Delayed programmed cell death was detected at 72-96 h after treatment. Endothelial functions were also affected by inhibition of cPLA(2) during irradiation resulting in attenuated cell migration and tubule formation. The role of cPLA(2) in the regulation of radiation-induced activation of Akt and ERK1/2 and cell viability was confirmed using human umbilical vein endothelial cells transfected with shRNA for cPLA(2)alpha and cultured embryonic fibroblasts from cPLA(2)alpha(-/-) mice. In summary, an immediate radiation-induced cPLA(2)-dependent signaling was identified that regulates cell viability and, therefore, represents one of the key regulators of radioresistance of vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566601     DOI: 10.1038/cdd.2008.93

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  19 in total

Review 1.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

2.  Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer.

Authors:  Rachael R Schulte; Amanda G Linkous; Dennis E Hallahan; Eugenia M Yazlovitskaya
Journal:  Cancer Lett       Date:  2011-05-28       Impact factor: 8.679

3.  p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice.

Authors:  Chang-Lung Lee; Everett J Moding; Kyle C Cuneo; Yifan Li; Julie M Sullivan; Lan Mao; Iman Washington; Laura B Jeffords; Rafaela C Rodrigues; Yan Ma; Shiva Das; Christopher D Kontos; Yongbaek Kim; Howard A Rockman; David G Kirsch
Journal:  Sci Signal       Date:  2012-07-24       Impact factor: 8.192

Review 4.  Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

Authors:  Jeffrey M Craft; Dennis Hallahan
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

5.  Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.

Authors:  Yunguang Sun; Luigi Moretti; Nicholas J Giacalone; Stephen Schleicher; Christina K Speirs; David P Carbone; Bo Lu
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

Review 6.  Phospholipase signalling networks in cancer.

Authors:  Jong Bae Park; Chang Sup Lee; Jin-Hyeok Jang; Jaewang Ghim; Youn-Jae Kim; Sungyoung You; Daehee Hwang; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

7.  Interleukin-32 positively regulates radiation-induced vascular inflammation.

Authors:  Hanako Kobayashi; Eugenia M Yazlovitskaya; P Charles Lin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-01       Impact factor: 7.038

Review 8.  Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

Authors:  Andrei Laszlo; Dinesh Thotala; Dennis E Hallahan
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

9.  Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature.

Authors:  Ling Geng; Girish Rachakonda; D James Morré; Dorothy M Morré; Peter A Crooks; Vijayakumar N Sonar; Joseph L Roti Roti; Buck E Rogers; Suellen Greco; Fei Ye; Kenneth J Salleng; Soumya Sasi; Michael L Freeman; Konjeti R Sekhar
Journal:  FASEB J       Date:  2009-04-24       Impact factor: 5.191

10.  Activation of cytosolic phospholipase A2-{alpha} as a novel mechanism regulating endothelial cell cycle progression and angiogenesis.

Authors:  Shane P Herbert; Adam F Odell; Sreenivasan Ponnambalam; John H Walker
Journal:  J Biol Chem       Date:  2009-01-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.